OnCo
ideasIdea

Mandatory staged registries for new surgical techniques before wide adoption

New operations and surgical devices spread by enthusiasm, not evidence. Every new technique would have to be entered in a registry that tracks patients through defined stages before it can be widely used and paid for.

Regulators and payers require that new cancer surgical techniques and devices follow the IDEAL framework (idea, development, exploration, assessment, long-term study), with a prospective registry from first use, defined triggers for moving to a randomised comparison, and reimbursement conditional on registry participation until assessment is complete. Devices already need regulatory clearance but techniques need none, and both diffuse before evidence exists (robotic prostatectomy, minimally invasive radical hysterectomy, cytoreductive surgery with HIPEC). Registries also produce the learning-curve and volume data needed for credentialling.

Hypothesis
Mandatory staged registries reduce the time from first use to a randomised or IDEAL stage 3 comparison for new cancer surgical techniques from more than a decade to under five years, and detect harmful diffusion (as with minimally invasive radical hysterectomy) before it becomes standard.
Rationale
The LACC trial found worse survival with minimally invasive radical hysterectomy after the technique had spread for years without randomised evidence; national joint replacement registries have detected failing implants years before regulators. Coverage-with-evidence-development has worked for several devices in the US and UK.
What would test it
Pilot in one country for three new techniques or devices, measuring registry completeness, time to comparative evidence and the frequency of adoption decisions changed by registry data.
Maturity
early clinical
Who has to act
regulator
Cost to try
Medium ($1M to $50M)
Years to first evidence
3
Bottlenecks it attacks

Connected

14top

Pages like this

not linked directly; found by shared links

cancers

3
Cervical cancerColorectal cancerProstate cancer

technologies

3
Focused ultrasound & histotripsyHIPEC / PIPAC (intraperitoneal chemotherapy)Robotic & minimally invasive surgery

companies

1
Intuitive Surgical

ideas

5
A translation fund for academic surgical devices and radiotherapy technologyA video-based surgical quality registry linking assessed skill to cancer outcomesAn independent evaluation unit for surgical robots and AI, paid on evidenceDevice-agnostic public trials of ablation technologies against surgeryPublic risk-adjusted outcome reporting for cancer surgery to drive centralisation

bottlenecks

2
Surgery and radiotherapy cure most, get leastWeak real-world evidence and registries